Table 2. The clinicopathological characteristics of 30 esophageal cancer patients.
Characteristics | Case number |
---|---|
Sex | |
Female | 7 (23.3%) |
Male | 23 (76.7%) |
Age | |
<60 | 15 (50.0%) |
≥60 | 15 (50.0%) |
Tumor location | |
Upper | 7 (23.3%) |
Middle | 6 (20.0%) |
Lower | 17 (56.7%) |
Depth of invasion (pT) | |
Adjacents structures | 2 (6.6%) |
Adwentitia | 15 (50%) |
Muscularis mucosa | 1 (3.3%) |
Muscularis propria | 11 (36.6%) |
Submucosa | 1 (3.3%) |
Lymph node metastasis (pN) * | |
0 | 19 (63.3%) |
1 | 3 (10.0%) |
2 | 2 (6.6%) |
3 | 2 (6.6%) |
4 | 2 (6.6%) |
5 | 2 (6.6%) |
Pathological stage(pStage) * | |
IA | 1 (3.3%) |
IB | 1 (3.3%) |
IC | 7 (23.3%) |
IIA | 2 (6.6%) |
IIB | 8 (26.6%) |
IIIA | 2 (6.6%) |
IIIB | 8 (26.6%) |
IVA | 1 (3.3%) |
Tumor differentiation | |
G1 | 13 (43.3%) |
G2 | 8 (26.6%) |
G3 | 9 (30%) |
Note:
Lymph node metastasis (pN) and pathological stages (pStage) were determined according to the Unio Internationalis Contra Cancrum (UICC) 8th edition.